Will Landos Biopharma (NASDAQ:LABP) Spend Its Cash Wisely? [Yahoo! Finance]
Landos Biopharma, Inc. (LABP)
Company Research
Source: Yahoo! Finance
By way of example, Landos Biopharma NASDAQ:LABP ) has seen its share price rise 112% over the last year, delighting many shareholders. But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. In light of its strong share price run, we think now is a good time to investigate how risky Landos Biopharma's cash burn is. For the purpose of this article, we'll define cash burn as the amount of cash the company is spending each year to fund its growth (also called its negative free cash flow). The first step is to compare its cash burn with its cash reserves, to give us its 'cash runway'. View our latest analysis for Landos Biopharma Does Landos Biopharma Have A Long Cash Runway? You can calculate a company's cash runway by dividing the amount of cash it has by the rate at which it is spending that cash. As at September 2023, Landos Biopharma had cash of US$42m and no debt. In the last year, its cash burn was US$19m. Therefore, from S
Show less
Read more
Impact Snapshot
Event Time:
LABP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LABP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LABP alerts
High impacting Landos Biopharma, Inc. news events
Weekly update
A roundup of the hottest topics
LABP
News
- AbbVie (ABBV) Q1 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbViePR Newswire
- SHAREHOLDER ALERT: Weiss Law Investigates Landos Biopharma, Inc.Accesswire
- Landos Biopharma, Inc. (NASDAQ: LABP) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $20.42 price target on the stock, down previously from $50.00.MarketBeat
- LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LABPBusiness Wire
LABP
Analyst Actions
- 4/1/24 - HC Wainwright
LABP
Sec Filings
- 4/25/24 - Form DEFM14A
- 4/16/24 - Form 10-K/A
- 4/15/24 - Form PREM14A
- LABP's page on the SEC website